维普期刊资源整合服务平台（V6.5）

87篇 您的检索式：作者名="Hutson E"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘	Brian I Rini Bernard Escudier Piotr Tomczak Andrey Kaprin Cezary Szczylik Thomas E Hutson M Dror Michaelson Vera A Gorbunova Martin E Gore Igor G Rusakov Sylvie Negrier Yen-Chuan Ou Daniel Castellano Ho Yeong Lim Hirotsugu Uemura Jamal Tarazi David Cella	2011	The Lancet . 2011 (9807)2011，，9807：	2
2	Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial显示文摘	Thomas E Hutson Vladimir Lesovoy Salman Al-Shukri Viktor P Stus Oleg N Lipatov Angel H Bair Brad Rosbrook Connie Chen Sinil Kim Nicholas J Vogelzang	2013	Lancet Oncology2013，，13：	2
3	Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘	Brian I Rini Bernard Escudier Piotr Tomczak Andrey Kaprin Cezary Szczylik Thomas E Hutson M Dror Michaelson Vera A Gorbunova Martin E Gore Igor G Rusakov Sylvie Negrier Yen-Chuan Ou Daniel Castellano Ho Yeong Lim Hirotsugu Uemura Jamal Tarazi David Cella	2011	The Lancet2011，，9807：	2
4	Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial显示文摘	Robert J Motzer Bernard Escudier Stéphane Oudard Thomas E Hutson Camillo Porta Sergio Bracarda Viktor Grünwald John A Thompson Robert A Figlin Norbert Hollaender Gladys Urbanowitz William J Berg Andrea Kay David Lebwohl Alain Ravaud	2008	The Lancet2008，，9637：	2
5	Sunitinib versus interferon alfa in metastatic renal-cell carcinoma显示文摘	MOTZER R J HUTSON T E TOMCZAK P	2007	N Engl J Med2007，356，2：	1
6	Suni- tinib versus interferon alfa in metastatic renal-cell carcinoma显示文摘	MOTZER R J HUTSON T E TOMCZAK P	2007	N Engl J Med2007，356，2：	1
7	Abiraterone acetate:a promising drug for the treatment of castra- tion-resistant prostate cancer 显示文摘	AGARWAJ N HUTSON T E VOGELZANG N J	2010	Future Oncol2010，6，5：	1
8	Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma显示文摘	Motzer R J Hutson T E Tomczak P	2009	J Clin Oncol2009，27，22：	1
9	Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma 显示文摘	Hutson T E Davis I D Machiels J P	2010	JClin Oncol2010，28，3：	1
10	Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-or显示文摘	PATIL S FIGLIN R A HUTSON T E	2012	Br J Cancer2012，106，15：	1
11	Falvonol content and composition of spring onion growth hydroponically or in potting soil显示文摘	Thompson L Morris J Peffley E Green C Pare P Tissue D Jasoni R Hutson J Wehner B Kane C	2005	Journal of Food Composition and Analysis2005，18，：	1
12	Capital structure in new techno- logy based firms :evidence from the Irish software sector 显示文摘	Hogan T Hutson E	2005	Global Finance Journal2005，15，3：	1
13	Sunitinib versus interferon-alfa in metaslatic renal-ceil carcinoma显示文摘	Motzer R J Hutson T E Tomczak P	2007	N EnglJ Med2007，356，：	1
14	Liquid chromato- graphic determination of hydroxyproline in tissue显示文摘	Hutson P R Crawford M E Sorkness R L	2003	J Chromatogr B2003，791，：	1
15	Sunitinib versus interferon alfa in metastatic renal-cell carcinoma 显示文摘	Motzer R J Hutson T E Tomczak P	2007	N Engl J Med2007，356，2：	1
16	Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma显示文摘	Motzer R J Hutson T E Tomczak P Michaelson M D Bukowski R M Oudard S	2009	J Clin Oncol2009，27，：	1
17	Randomized phase 111 trial of temsimlimus versus sorafenib as second- line therapy after sunitinib in patients with metastatic re- nal cell carcinoma 显示文摘	Hutson TE Escudier B Esteban E	2014	J Clin Oneol2014，32，8：	1
18	Time course of NADH oxidase,inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat显示文摘	ELLIS E A GUBERSKI D L HUTSON B	2002	Nitric Oxide2002，6，3：	1
19	Sunitinib versus interferon alfa in metastatic renal-cell carcinoma 显示文摘	MOTZER R J HUTSON T E TOMCZAK P	2007	N Engl J Med2007，356，2：	1
20	Pazopanib: a novel muhitargeted tyrosine kinase inhibitor 显示文摘	Sonpavde G Hutson T E	2007	Curr Oncol Rep2007，，9：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示